Kate Buchacz1, Carl Armon2, Frank J Palella3, Richard M Novak4, Jack Fuhrer5, Ellen Tedaldi6, Douglas Ward7, Cynthia Mayer8, Linda Battalora2,9, Kimberly Carlson2, Stacey Purinton2, Marcus Durham1, Jun Li1. 1. Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 2. Cerner Corporation, Kansas City, Missouri, USA. 3. Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. 4. University of Illinois College of Medicine, Chicago, Illinois, USA. 5. Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA. 6. Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA. 7. Dupont Circle Physicians Group, Washington, DC, USA. 8. St. Joseph's Hospital Comprehensive Research Institute, Tampa Florida, USA. 9. Colorado School of Mines, Golden, Colorado, USA.
Abstract
Background: The clinical epidemiology of treated HIV infection in the United States has dramatically changed in the past 25 years. Few sources of longitudinal data exist for people with HIV (PWH) spanning that period. Cohort data enable investigating new exposure and disease associations and monitoring progress along the HIV care continuum. Methods: We synthesized key published findings and conducted primary data analyses in the HIV Outpatient Study (HOPS), an open cohort of PWH seen at public and private HIV clinics since 1993. We assessed temporal trends in health outcomes (1993-2017) and mortality (1994-2017) for 10 566 HOPS participants. Results: The HOPS contributed to characterizing new conditions (eg, lipodystrophy), demonstrated reduced mortality with earlier HIV treatment, uncovered associations between select antiretroviral agents and cardiovascular disease, and documented remarkable shifts in morbidity from AIDS opportunistic infections to chronic noncommunicable diseases. The median CD4 cell count of participants increased from 244 cells/mm3 to 640 cells/mm3 from 1993 to 2017. Mortality fell from 121 to 16 per 1000 person-years from 1994 to 2017 (P < .001). In 2010, 83.7% of HOPS participants had a most recent HIV viral load <200 copies/mL, compared with 92.2% in 2017. Conclusions: Since 1993, the HOPS has been detecting emerging issues and challenges in HIV disease management. HOPS data can also be used for monitoring trends in infectious and chronic diseases, immunologic and viral suppression status, retention in care, and survival, thereby informing progress toward the Ending the HIV Epidemic initiative. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020.
Background: The clinical epidemiology of treated HIV infection in the United States has dramatically changed in the past 25 years. Few sources of longitudinal data exist for people with HIV (PWH) spanning that period. Cohort data enable investigating new exposure and disease associations and monitoring progress along the HIV care continuum. Methods: We synthesized key published findings and conducted primary data analyses in the HIV Outpatient Study (HOPS), an open cohort of PWH seen at public and private HIV clinics since 1993. We assessed temporal trends in health outcomes (1993-2017) and mortality (1994-2017) for 10 566 HOPS participants. Results: The HOPS contributed to characterizing new conditions (eg, lipodystrophy), demonstrated reduced mortality with earlier HIV treatment, uncovered associations between select antiretroviral agents and cardiovascular disease, and documented remarkable shifts in morbidity from AIDS opportunistic infections to chronic noncommunicable diseases. The median CD4 cell count of participants increased from 244 cells/mm3 to 640 cells/mm3 from 1993 to 2017. Mortality fell from 121 to 16 per 1000 person-years from 1994 to 2017 (P < .001). In 2010, 83.7% of HOPS participants had a most recent HIV viral load <200 copies/mL, compared with 92.2% in 2017. Conclusions: Since 1993, the HOPS has been detecting emerging issues and challenges in HIV disease management. HOPS data can also be used for monitoring trends in infectious and chronic diseases, immunologic and viral suppression status, retention in care, and survival, thereby informing progress toward the Ending the HIV Epidemic initiative. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020.
Entities:
Keywords:
HIV epidemiology; antiretroviral therapy; clinical outcomes; viral suppression
Authors: Taraz Samandari; Ellen Tedaldi; Carl Armon; Rachel Hart; Joan S Chmiel; John T Brooks; Kate Buchacz Journal: Open Forum Infect Dis Date: 2017-06-10 Impact factor: 3.835
Authors: K A Lichtenstein; D J Ward; A C Moorman; K M Delaney; B Young; F J Palella; P H Rhodes; K C Wood; S D Holmberg Journal: AIDS Date: 2001-07-27 Impact factor: 4.177
Authors: Ellen M Tedaldi; Rose K Baker; Anne C Moorman; Carlos F Alzola; Jack Furhrer; Robert E McCabe; Kathleen C Wood; Scott D Holmberg Journal: Clin Infect Dis Date: 2003-01-14 Impact factor: 9.079
Authors: Marcus D Durham; Kate Buchacz; Jim Richardson; DerShung Yang; Kathy Wood; Bienvenido Yangco; John T Brooks Journal: J Acquir Immune Defic Syndr Date: 2013-07-01 Impact factor: 3.731
Authors: Angela M Thompson-Paul; Kenneth A Lichtenstein; Carl Armon; Frank J Palella; Jacek Skarbinski; Joan S Chmiel; Rachel Hart; Stanley C Wei; Fleetwood Loustalot; John T Brooks; Kate Buchacz Journal: Clin Infect Dis Date: 2016-09-09 Impact factor: 9.079
Authors: Magdalena E Sobieszczyk; Donald R Hoover; Kathryn Anastos; Kathleen Mulligan; Tianren Tan; Qiuhu Shi; Wei Gao; Charles Hyman; Mardge H Cohen; Stephen R Cole; Michael W Plankey; Alexandra M Levine; Jessica Justman Journal: J Acquir Immune Defic Syndr Date: 2008-07-01 Impact factor: 3.731
Authors: Bienvenido G Yangco; Kate Buchacz; Rose Baker; Frank J Palella; Carl Armon; John T Brooks Journal: AIDS Patient Care STDS Date: 2014-05-15 Impact factor: 5.078
Authors: Kate Buchacz; Emma L Frazier; H Irene Hall; Rachel Hart; Ping Huang; Dana Franklin; Xiaohong Hu; Frank J Palella; Joan S Chmiel; Richard M Novak; Kathy Wood; Bienvenido Yangco; Carl Armon; John T Brooks; Jacek Skarbinski Journal: Open AIDS J Date: 2015-12-07
Authors: Jun Li; Carl Armon; Frank J Palella; Ellen Tedaldi; Richard M Novak; Jack Fuhrer; Gina Simoncini; Kimberly Carlson; Kate Buchacz Journal: Open Forum Infect Dis Date: 2021-04-17 Impact factor: 3.835